These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28870503)

  • 1. [Prospective study of the incidence of cardiovascular events in young adults and its relation to the metabolic syndrome].
    González-Solanellas M; Puig Esmandia M; Rodriguez Blanco P; Zabaleta-Del-Olmo E
    Aten Primaria; 2018 Jan; 50(1):67-69. PubMed ID: 28870503
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med; 2019 Dec; 171(12):. PubMed ID: 31766054
    [No Abstract]   [Full Text] [Related]  

  • 3. Equality or disparity? Cardiovascular risk factors and their correlation within the metabolic syndrome. The secret of gods.
    Sousa RA; Manuel GJ; Vicente C
    Diabetes Metab Syndr; 2019; 13(2):1393-1398. PubMed ID: 31336498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome as a prohypertensive state.
    Mulé G; Cerasola G
    Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
    Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
    Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperleptinemia, hyperinsulinemia and metabolic syndrome in cardiovascular risk: one for all and all for one].
    Botella Carretero JI
    Med Clin (Barc); 2004 Dec; 123(20):780-1. PubMed ID: 15607071
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults.
    Akosah KO; McHugh VL; Mathiason MA; Kulkarni A; Barnhart SI
    J Cardiometab Syndr; 2006; 1(3):173-7. PubMed ID: 17679809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, subclinical coronary atherosclerosis, and cardiovascular risk.
    Campbell CY; Nasir K; Blumenthal RS
    Am Heart Hosp J; 2005; 3(2):105-10. PubMed ID: 15860997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for diagnosing the metabolic syndrome.
    Oda E
    Am J Clin Nutr; 2006 Nov; 84(5):1251-2; author reply 1252. PubMed ID: 17093185
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.
    Cheng JY; Wong VW; Tse YK; Chim AM; Chan HL; Wong GL
    Hepatology; 2016 Nov; 64(5):1507-1517. PubMed ID: 27680510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study].
    Goday A; Gabriel R; Ascaso JF; Franch J; Ortega R; Martínez O; Lerones N;
    Rev Clin Esp; 2008 Sep; 208(8):377-85. PubMed ID: 18817695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.
    Zhang ML; Hou XH; Zhu YX; Lu JX; Peng LP; Gu HL; Jia WP
    Biomed Environ Sci; 2012 Feb; 25(1):38-45. PubMed ID: 22424625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome.
    Dominiczak MH
    Curr Opin Lipidol; 2003 Jun; 14(3):329-32. PubMed ID: 12840663
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
    Hanna FW
    Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome in clinical practice.
    Katsiki N; Athyros VG; Karagiannis A
    Cardiol J; 2014; 21(2):209. PubMed ID: 24752952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors].
    Abacı A; Kılıçkap M; Göksülük H; Karaaslan D; Barçın C; Kayıkçıoğlu M; Özer N; Yılmaz MB; Şahin M; Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2018 Oct; 46(7):591-601. PubMed ID: 30391988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic syndrome: still undefined, but usefull to identify high risk for cardiovascular disease].
    Saad MJ; Zanella MT; Ferreira SR
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):161-2. PubMed ID: 16767281
    [No Abstract]   [Full Text] [Related]  

  • 19. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
    Houston MC; Basile J; Bestermann WH; Egan B; Lackland D; Hawkins RG; Moore MA; Reed J; Rogers P; Wise D; Ferrario CM
    Am J Med Sci; 2005 Jun; 329(6):276-91. PubMed ID: 15958870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease, hypertension, and prevention: "from endothelium to clinical events".
    Hirsch AT
    J Am Coll Cardiol; 2003 Jul; 42(2):377-9. PubMed ID: 12875780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.